MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
25.91
+0.53 (+2.09%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close25.38
Open25.70
Bid0.00 x 800
Ask0.00 x 900
Day's Range25.70 - 26.05
52 Week Range19.93 - 39.96
Volume1516195
Avg. Volume1,129,209
Market Cap2.2B
Beta (3Y Monthly)0.76
PE Ratio (TTM)N/A
EPS (TTM)-17.07
Earnings DateFeb 5, 2020 - Feb 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.42
  • Here's Why Should You Hold MEDNAX (MD) in Your Portfolio
    Zacks

    Here's Why Should You Hold MEDNAX (MD) in Your Portfolio

    Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.

  • Reduce Holdings of These 2 Stocks
    GuruFocus.com

    Reduce Holdings of These 2 Stocks

    They have underperformed the market Continue reading...

  • Why Is Mednax (MD) Up 18.9% Since Last Earnings Report?
    Zacks

    Why Is Mednax (MD) Up 18.9% Since Last Earnings Report?

    Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • MEDNAX (MD) Ties Up With Homestead to Expand in Florida
    Zacks

    MEDNAX (MD) Ties Up With Homestead to Expand in Florida

    MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.

  • 7 Sickly Healthcare Stocks to Avoid
    InvestorPlace

    7 Sickly Healthcare Stocks to Avoid

    If we can be sure of one thing in 2019, it's that not all stocks are created equal.We have seen sectors rise and some of the big names falter all the same. This has certainly been a stock picker's market.And I say that knowing full well that the S&P 500 is up an impressive 26% year-to-date.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut healthcare is a tricky sector because it incorporates a variety of stocks -- from drug companies to hospitals to insurers to medical device makers. All are on different sales calendars and don't march in lockstep.The thing to watch in the sector is how the economy is doing. If people are working then they have more money, and they will use some of that money for healthcare purposes.As far as legislation that can clear up the direction of the U.S. healthcare system, that is a long way away. * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities For now, it's best to stick with only the most powerful stocks the market has to offer -- and avoid the weakest. And the doctor is ordering you to banish these seven sickly healthcare stocks from your portfolio, if you've got them. Healthcare Stocks to Sell: Mednax (MD)Source: IgorGolovniov / Shutterstock.com Mednax (NYSE:MD) is a Florida-based firm that has been supplying physician services for anesthesia, pediatric specialties and newborns since 1976.These contract services have been in big demand for a while, as the healthcare landscape was developing under new "Obamacare" legislation.But those days are passed and healthcare organizations are settling in the current state of limbo. But that means staffing is a bit more predictable and MD's services are finding fewer customers.MD has begun restructuring to get back in step with market conditions. Whether that works or not, remains to be seen. But it's getting downgraded across the board and year-over-year revenue is declining. There's more downside than upside left for this stock. Fresenius Medical Care (FMS)Source: OleksandrShnuryk / Shutterstock.com Fresenius Medical Care (NYSE:FMS) has been doing pretty well this year, relative to the category it finds itself in today.This Germany-based firm specializes in treatment and services for patients with chronic kidney failure and is one of the top providers, along with DaVita (NYSE:DVA). The problem is, while this is a growth sector, especially in the United States, Medicare is tight with its payments, so the margins are low. And solid operating margins are crucial to the profitability standards I set for any investment.In July, President Donald Trump issued an executive order allowing in-home services for kidney dialysis and other treatments and both sector-leading stocks popped.But it may not be FMS that is the biggest winner, especially given the fact that its dialysis clinics and home services would initially add to costs. This is ultimately a win for insurers rather than these specialized companies. * 7 Killer Stocks No One Knows About The stock is only down 3% in the past year, but it's up 13% year-to-date, so this performance is showing a downtrend is still in place. Healthcare Services Group (HCSG)Source: Shutterstock Healthcare Services Group (NASDAQ:HCSG) is a good example of a middling company in the ancillary services sector of the healthcare industry -- including laundry and dietary services for long-term care facilities -- that has been struggling between strength and weakness for a while.It's a good sector and it is a pretty big name in the industry, having been around since 1976. But the dynamics in this sector are shifting, as the insurance industry would prefer to pay to keep people at home, rather than pay for facilities. The same goes for Medicare.Struggles with margins have been ongoing. And then in late October, third-quarter earnings hammered the company. While revenue was in line with expectations, earnings missed by almost 10%. That's not encouraging.It also means analysts cut their price targets moving forward and institutional investors are looking to move their money, further driving down the stock. Brookdale Senior Living (BKD)Source: Pavel Kapysh / Shutterstock.com Brookdale Senior Living (NYSE:BKD) provides senior living communities to more than 75,000 residents. It has been in business since 2005.During that time, BKD has been able to capture the first wave of baby boomers and the tail end of their parents heading into assisted living facilities. And this market looked like it was going to expand for decades as boomers started filling up these facilities in huge numbers.Now, real estate is an area I'd consider crucial to my Growth Investor strategy … if the business model is strong. But along the way, technology has shifted this particular trend. In-home care has increased and there is now more care that can be conducted from homes due to advances in equipment.This means assisted living facilities are under pressure. They proliferated, anticipating a growing base, and now that growth looks to be less than expected. Given the fact that they've dumped huge sums in large campuses, this is not the "sure thing" it was five years ago. * 9 Tantalizing Dividend Stocks for 2020 There will be growing competition in this sector and Medicare and insurers will have some leverage here, all challenging BKD's margins in coming quarters, if not years. HCA Healthcare (HCA)Source: Trismegist san / Shutterstock.com HCA Healthcare (NYSE:HCA) is a for-profit company that operates hospitals, urgent care facilities, outpatient services facilities and the like.It was founded in 1968 and comprises nearly 250,000 employees in 21 states, including 38,000 physicians and 87,000 nurses. It's No. 63 in the Fortune 500.This isn't a stock or company teetering on the brink of existence. But it will be in an increasingly challenging sector moving forward.The graying of America was supposed to be a boon for these types of companies. But the real challenge underneath it all is how Americans pay for all of this increased healthcare.Insurance companies are not interested in expanding the margins for hospital companies. And Medicare is already under pressure for funding as it is; more people in the system won't help its generosity.This is one of those stocks that may not fall significantly, but it won't rise much either. There are simply better places to put your money to work. Cigna (CI)Source: Piotr Swat / Shutterstock.com Cigna (NYSE:CI) is one of the leading health insurers in the U.S. and beyond. It has a $75 billion market capitalization and has been around since 1792. Nope, that not a typo, it's 227 years old.It bought the first insurer in America -- Insurance Company of North America -- in a 1982 merger. That's some serious staying power.Recently, this sector has been under duress because Wall Street was worried that Democratic presidential candidate Elizabeth Warren was going to destroy the health insurance industry with her Medicare for All health coverage program.But Warren recently laid out the plan and it looks like such an outcome would be at least three years out if she were to be elected. And that means it would be up for implementation as she ran for a second term, which gives companies even more time. * 10 Cheap Stocks to Buy Under $10 CI and other insurers were all part of a relief rally. But the fact is, the popularity of Medicare for All isn't lost on these big insurers. And it's going to be a tough transition to come up with a better private solution or figure out what to do when the current system transitions. In the meantime, I see much stronger stocks out there. Encompass Health (EHC)Source: Piotr Swat / Shutterstock.com Encompass Health (NYSE:EHC) provides post-acute healthcare services, such as inpatient and in-home rehabilitation as well as hospice care.Basically, it's part of a growth sector that benefits from the graying U.S. population as well as the trend to provide services outside brick-and-mortar corporate facilities.And its home care services are broader than simply rehabilitation. It provides nursing care as well as physical therapy. Also, its physical therapy division is available to people of all ages that are in need of rehabilitation services.The trouble is, this sector is in its early days and the industry is undergoing some volatility, given the vague future of U.S. healthcare policy, and thus, how companies can best adapt.Plus, the enthusiasm for this sector a few years ago has made stocks like EHC relatively expensive, so its valuations aren't in line with the current state of the sector. Wall Street doesn't like surprises, and this sector may be full of them in coming quarters.There are certainly worse stocks out there, but there are also better ones right now. Why I Like Dividend Growth Stocks NowIf you think what happened in the stock market the last few months is wild, just look at the bond market. We've got falling and even negative yields overseas. But as investors retreat to U.S. Treasuries it's causing bizarre effects here, too. Just look at what happened this summer, when the two-year Treasury actually began to yield MORE than the 10-year Treasury. And even the 30-year Treasury can't be relied upon for good yield anymore.So if a stock's earnings picture is uncertain, not only is it going to be volatile, but people are going to look elsewhere seeking income.Meanwhile, other stocks not only earn an "A" in my Portfolio Grader, thanks to strong buying pressure and great fundamentals …The stocks also earn an "A" in my Dividend Grader. These stocks are able to pay great yields -- and have the strong business model to back it up.All in all, I've got 29 strong dividend growth stocks for you now in Growth Investor -- averaging 4% yields -- far more than the S&P 500 or even a Treasury bond. These stocks are poised to do well as we continue to see international capital flow to the U.S. markets. Click here to see how I found these stocks, and how you can get great performance out of YOUR portfolio -- come what may.Louis Navellier had an unconventional start, as a grad student who accidentally built a market-beating stock system -- with returns rivaling even Warren Buffett. In his latest feat, Louis discovered the "Master Key" to profiting from the biggest tech revolution of this (or any) generation. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities * 7 High-Yield ETFs to Buy Now * 4 Dow Jones Industrial Average Stocks to Sell The post 7 Sickly Healthcare Stocks to Avoid appeared first on InvestorPlace.

  • Business Wire

    MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Critical Care and Hospitalist Practice

    MEDNAX, Inc. (MD), today announced its affiliation with Arcenio Chacón, M.D., P.A. and Associated Pediatricians of Homestead, LLC, a private pediatric critical care and hospitalist practice based in Miami. Founded in 1993, the practice is a well-established group that has served Baptist Health South Florida for more than 25 years. Comprising four physicians, the group provides pediatric critical care and hospitalist services at Baptist Children's Hospital and hospitalist services at Miami Cancer Institute and Homestead Hospital.

  • Business Wire

    MEDNAX Radiology Solutions and vRad to Exhibit at the RSNA 2019 Annual Meeting Dec. 1-6

    MEDNAX Radiology Solutions, one of the nation’s leading radiology practices, and Virtual Radiologic , a MEDNAX company, will exhibit at the Radiological Society of North America’s 2019 Annual Meeting from Dec.

  • MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative
    Zacks

    MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative

    MEDNAX (MD) receives rating affirmations from Moody's. However, the outlook is changed to negative.

  • Business Wire

    MEDNAX to Present at Upcoming Investor Conferences

    MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.

  • Moody's

    MEDNAX, Inc. -- Moody's changes MEDNAX's outlook to negative, affirms ratings

    Moody's Investors Service ("Moody's") affirmed MEDNAX, Inc.'s ("MEDNAX") Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating and the Ba2 rating on its unsecured bonds due in 2023 and 2027. At the same time, the outlook was changed to negative from stable.

  • Thomson Reuters StreetEvents

    Edited Transcript of MD earnings conference call or presentation 1-Nov-19 1:00pm GMT

    Q3 2019 MEDNAX Inc Earnings Call

  • MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
    Zacks

    MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y

    MEDNAX's (MD) results reflect escalating expenses in the third quarter.

  • Mednax (MD) Q3 Earnings Meet Estimates
    Zacks

    Mednax (MD) Q3 Earnings Meet Estimates

    Mednax (MD) delivered earnings and revenue surprises of 0.00% and 1.75%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    MEDNAX Reports Third Quarter Results

    Completes Sale of MedData Business to Frazier Healthcare Partners

  • Why Earnings Season Could Be Great for MEDNAX (MD)
    Zacks

    Why Earnings Season Could Be Great for MEDNAX (MD)

    MEDNAX (MD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Business Wire

    MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Plastic Surgery Practice

    MEDNAX, Inc. (MD), today announced its affiliation with Eric Stelnicki, M.D., P.A., a private pediatric plastic surgery practice based in Fort Lauderdale, Fla. Founded in 2001, the group specializes in pediatric plastic surgery; craniofacial surgery; maxillofacial surgery; ear reconstruction; cleft lip and cleft palate; treatment of vascular lesions (hemangiomas), burns, scars, pediatric wounds and skin lesions; and pediatric hand surgery. The practice holds teaching relationships with Cleveland Clinic Florida, Barry University and Nova University.

  • Cigna (CI) to Report Q3 Earnings: What's in the Offing?
    Zacks

    Cigna (CI) to Report Q3 Earnings: What's in the Offing?

    Cigna (CI) Q3 earnings are likely to have benefited from higher contribution across all its segments and effect of share buyback.

  • What's in Store for Molina Healthcare (MOH) Q3 Earnings?
    Zacks

    What's in Store for Molina Healthcare (MOH) Q3 Earnings?

    Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.

  • What to Expect for WellCare Health's (WCG) Earnings in Q3
    Zacks

    What to Expect for WellCare Health's (WCG) Earnings in Q3

    WellCare Health's (WCG) Q3 results are likely to reflect increased revenues and higher membership, partly offset by elevated expenses.

  • Mednax (MD) Expected to Beat Earnings Estimates: Should You Buy?
    Zacks

    Mednax (MD) Expected to Beat Earnings Estimates: Should You Buy?

    Mednax (MD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Mednax Inc. (MD) Going To Burn These Hedge Funds ?
    Insider Monkey

    Is Mednax Inc. (MD) Going To Burn These Hedge Funds ?

    Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]

  • HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect
    Zacks

    HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect

    HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.

  • Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
    Zacks

    Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y

    Anthem's (ANTM) third-quarter earnings gain from increased revenues.

  • Centene's (CNC) Q3 Earnings and Revenues Beat Estimates
    Zacks

    Centene's (CNC) Q3 Earnings and Revenues Beat Estimates

    Centene's (CNC) third-quarter earnings gain traction from higher revenues.

  • What to Expect for Universal Health's (UHS) Q3 Earnings
    Zacks

    What to Expect for Universal Health's (UHS) Q3 Earnings

    Universal Health (UHS) is likely to have benefited from strong segmental performances at Acute Care and Behavioral Health in Q3, partly offset by high costs.